{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:40Z","timestamp":1753891900020,"version":"3.41.2"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Accessibility of treatment with monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) signaling pathway is impeded by regulatory restrictions. Affected individuals may seek out other services including non-pharmacological therapies. Thus, we found it timely to ascertain the use of non-pharmacological therapies in individuals with treatment-resistant migraine eligible for and na\u00efve to treatment with CGRP-signaling targeting monoclonal antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a single-center cross-sectional observational study of patients eligible for and na\u00efve to treatment with monoclonal antibodies targeting CGRP or its receptor. We recorded demographical information (gender, age, educational level, employment status, and income), disease burden (frequency of headache days and migraine days), previous use of preventive pharmacological medications for migraine, and use of non-pharmacological therapies over the past 3 months including frequency of interventions, costs, and patient-reported assessment of efficacy on a 6-point scale (0: no efficacy, 5: best possible efficacy).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 122 patients between 17 June 2019 and 6 January 2020; 101 (83%) were women and the mean age was 45.2 \u00b1 13.3 years. One-third (<jats:italic>n<\/jats:italic> = 41 [34%]) had used non-pharmacological therapy within the past 3 months. Among these participants, the median frequency of different interventions was 1 (IQR: 1\u20132), the median number of monthly visits was 2.3 (IQR: 1.3\u20134), mean and median monthly costs were 1,086 \u00b1 1471, and 600 (IQR: 0\u20131200) DKK (1 EUR = ~7.5 DKK), respectively, and median patient-reported assessment of the efficacy of interventions was 2 (IQR: 0\u20133).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Even in a high-income country with freely accessible headache services and universal healthcare coverage, there was a non-negligible direct cost in parallel with low satisfaction for non-pharmacological therapies among patients at a tertiary headache center.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2022.935183","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T05:17:33Z","timestamp":1657689453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Single-Center Cross-Sectional Observational Study"],"prefix":"10.3389","volume":"3","author":[{"given":"Lucas","family":"Rundblad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Kjaer","family":"Cullum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Gil-Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Ulud\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thien Phu","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal Mohammad","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","article-title":"Migraine: epidemiology and systems of care","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","article-title":"Migraine","volume":"383","author":"Ashina","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","article-title":"Diagnosis and management of migraine in ten steps","volume":"17","author":"Eigenbrodt","year":"2021","journal-title":"Nat Rev Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","article-title":"Migraine: integrated approaches to clinical management and emerging treatments","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet."},{"article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume-title":"JAMA","year":"2013","key":"B6"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders","volume":"38","author":"Arnold","year":"2018","journal-title":"Cephalalgia."},{"key":"B8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/03331024211068073","article-title":"Prevalence of neck pain in migraine: a systematic review and meta-analysis","volume":"42","author":"Al-Khazali","year":"2022","journal-title":"Cephalalgia."},{"key":"B9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0333102420919998","article-title":"Increased neck muscle stiffness in migraine patients with ictal neck pain: a shear wave elastography study","volume":"40","author":"Hvedstrup","year":"2020","journal-title":"Cephalalgia."},{"key":"B10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/0333102419896369","article-title":"Ictal neck pain investigated in the interictal state \u2013 a search for the origin of pain","volume":"40","author":"Hvedstrup","year":"2020","journal-title":"Cephalalgia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s10194-018-0913-8","article-title":"Myofascial trigger points in migraine and tension-type headache","volume":"19","author":"Do","year":"2018","journal-title":"J Headache Pain."},{"key":"B12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.apmr.2015.12.006","article-title":"Additional effects of a physical therapy protocol on headache frequency, pressure pain threshold, and improvement perception in patients with migraine and associated neck pain: a randomized controlled trial","volume":"97","author":"Bevilaqua-Grossi","year":"2016","journal-title":"Arch Phys Med Rehabil."},{"key":"B13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0333102415597889","article-title":"Efficacy of interventions used by physiotherapists for patients with headache and migraine\u2014systematic review and meta-analysis","volume":"36","author":"Luedtke","year":"2016","journal-title":"Cephalalgia."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-021-01298-4","article-title":"Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment, A systematic review and meta-analysis","volume":"22","author":"Kr\u00f8ll","year":"2021","journal-title":"J Headache Pain."},{"key":"B15","unstructured":"2013"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.935183\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T05:17:36Z","timestamp":1657689456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.935183\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":15,"alternative-id":["10.3389\/fpain.2022.935183"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2022.935183","relation":{},"ISSN":["2673-561X"],"issn-type":[{"type":"electronic","value":"2673-561X"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"article-number":"935183"}}